RED CAT HOLDINGS INC (RCAT)
US75644T1007 - Common Stock
Taking everything into account, RCAT scores 3 out of 10 in our fundamental rating. RCAT was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. RCAT may be in some trouble as it scores bad on both profitability and health. RCAT is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
RCAT had negative earnings in the past year.
In the past year RCAT has reported a negative cash flow from operations.
RCAT had negative earnings in each of the past 5 years.
In the past 5 years RCAT always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -74.99%, RCAT is not doing good in the industry: 90.40% of the companies in the same industry are doing better.
RCAT has a worse Return On Equity (-141.75%) than 89.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -74.99% | ||
| ROE | -141.75% | ||
| ROIC | N/A |
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 10.92%, RCAT is not doing good in the industry: 76.80% of the companies in the same industry are doing better.
RCAT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RCAT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RCAT has been increased compared to 1 year ago.
RCAT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RCAT has been reduced compared to a year ago.
2.2 Solvency
RCAT has an Altman-Z score of 13.04. This indicates that RCAT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RCAT (13.04) is better than 91.20% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that RCAT is not too dependend on debt financing.
RCAT has a Debt to Equity ratio of 0.44. This is in the lower half of the industry: RCAT underperforms 69.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.04 |
ROIC/WACCN/A
WACC10.48%
2.3 Liquidity
A Current Ratio of 1.43 indicates that RCAT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.43, RCAT is doing worse than 80.00% of the companies in the same industry.
A Quick Ratio of 0.57 indicates that RCAT may have some problems paying its short term obligations.
With a Quick ratio value of 0.57, RCAT is not doing good in the industry: 92.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
RCAT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.85%.
The Revenue has grown by 49.70% in the past year. This is a very strong growth!
Measured over the past years, RCAT shows a very strong growth in Revenue. The Revenue has been growing by 176.68% on average per year.
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)49.7%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%-60.82%
3.2 Future
Based on estimates for the next years, RCAT will show a very strong growth in Earnings Per Share. The EPS will grow by 48.46% on average per year.
RCAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 141.21% yearly.
EPS Next Y54.1%
EPS Next 2Y48.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year117.29%
Revenue Next 2Y141.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RCAT. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 131.74, RCAT can be considered very expensive at the moment.
RCAT's Price/Forward Earnings ratio is in line with the industry average.
RCAT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 131.74 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as RCAT's earnings are expected to grow with 48.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.46%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RCAT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RED CAT HOLDINGS INC
NASDAQ:RCAT (12/20/2024, 8:00:01 PM)
After market: 11.05 +0.3 (+2.79%)10.75
+1.66 (+18.33%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners13.99%
Inst Owner Change-12.44%
Ins Owners21.24%
Ins Owner Change-1.63%
Market Cap811.30M
Analysts85
Price Target7.14 (-33.58%)
Short Float %11.85%
Short Ratio1.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-102.21%
Min EPS beat(2)-108.33%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-106.49%
Min EPS beat(4)-145.1%
Max EPS beat(4)-76.47%
EPS beat(8)1
Avg EPS beat(8)-89.52%
EPS beat(12)2
Avg EPS beat(12)-134.79%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-46.32%
Min Revenue beat(2)-63.42%
Max Revenue beat(2)-29.22%
Revenue beat(4)0
Avg Revenue beat(4)-25.17%
Min Revenue beat(4)-63.42%
Max Revenue beat(4)-1.15%
Revenue beat(8)2
Avg Revenue beat(8)-20.22%
Revenue beat(12)2
Avg Revenue beat(12)-34.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)55.56%
PT rev (3m)55.56%
EPS NQ rev (1m)-12.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)-36.37%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)20.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 131.74 | ||
| P/S | 49.26 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 30.02 | ||
| P/tB | 1299.69 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.54
EYN/A
EPS(NY)0.08
Fwd EY0.76%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.22
BVpS0.36
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -74.99% | ||
| ROE | -141.75% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.92% | ||
| FCFM | N/A |
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 15.08% | ||
| Cap/Sales | 1.48% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 13.04 |
F-Score3
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)137.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y54.1%
EPS Next 2Y48.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.7%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%-60.82%
Revenue Next Year117.29%
Revenue Next 2Y141.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.2%
OCF growth 3YN/A
OCF growth 5YN/A